Logo_AIHTA
  • Deutsch
  • Contact
    • Imprint
      • Privacy Notice
        • Newsletter
          • Sitemap
            Menu_button
            • News
              • About us
                • Research areas
                  • Research Projects
                    • Publications
                      • Search
                        • Announcements
                          • Events
                            • Newsletter
                              • Press release on our reports
                                • Press photos
                                  Video
                                  Video: What is HTA?    
                                  • Home
                                  • News

                                  News

                                  Leiste32


                                  Welcome to the homepage of AIHTA!

                                  AIHTA is an academic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                  In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                  Subscribe to newsletter

                                  Adobestock-5249570911
                                  ©stock.adobe.com

                                  Announcement

                                  Artificial Intelligence in health care with a focus on hospitals: Methodological considerations for Health Technology Assessment. A Scoping Review.

                                  Artificial Intelligence (AI) in healthcare comprises machine-based systems designed to imitate human cognitive abilities and is increasingly important in digital health technologies. An analysis of 51 Health Technology Assessment (HTA) institutions revealed that 13 institutions published a total of five methodological documents and 30 HTA reports, primarily focusing on diagnostic and screening applications (27/30), which mainly serve as support tools and require medical personnel decision-making.

                                  The analysis shows that standard HTA methods can serve as a starting point for evaluation, but AI-specific considerations are required for technical, ethical, and organisational aspects as well as implementation monitoring. The latter is particularly important as algorithms can change and need regular evaluation. Regulatory compliance requires adherence to the EU AI Act, Medical Device Regulation and General Data Protection Regulation. A mature digital infrastructure with high interoperability is considered a fundamental prerequisite for successful implementation.

                                  Publication: HTA Project Report No. 164: https://eprints.aihta.at/1546/
                                  Contact: Michaela Riegelnegg

                                  More...

                                  Bild-weight-stigma-ki-generiert1
                                  ©stock.adobe.com

                                  Announcement

                                  Strategies for reducing weight stigmatisation towards people with overweight or obesity in the healthcare system

                                  Every second person who is overweight or obese is generally affected by stigmatisation due to their body weight. The healthcare sector is cited as one of the most common causes. As a result, the affected patients may receive incorrect or no diagnoses and therapies, avoid examinations and suffer health consequences such as further weight gain. Through a systematic literature search, various guideline-based recommendations for reducing weight stigma towards overweight and obese people in healthcare settings were identified. Further, available evidence for investigated interventions was analysed.

                                  Publication: HTA Project Report  No. 160: https://eprints.aihta.at/1547/
                                  Contact: Sarah Wolf

                                  More...

                                  Adobestock-1958604771
                                  ©stock.adobe.com

                                  Announcement

                                  Oncological Breast Cancer Care in Selected European Countries- Cross-sectoral cancer care models

                                  The increasing incidence and prevalence of cancer, particularly breast cancer, presents substantial challenges for the Austrian healthcare system. The current hospital-centred care delivery model contributes to escalating costs and suboptimal resource utilisation.

                                  A comprehensive analysis of cancer care models across six European countries (Austria [AT], Germany [DE], Denmark [DK], Sweden [SE], Netherlands [NL], Belgium [BE]) was conducted through structured literature review, expert consultations (n=17), and data synthesis, focusing specifically on breast cancer care. Analysis of healthcare infrastructures and cross-sectoral care approaches throughout the patient journey identified three distinct models: centralised specialist models (AT, BE, DK) characterised by highly specialised centres with strict volume requirements; decentralised care (DE) featuring distributed hospital structures in the in- and outpatient setting; and network-based integrated care (NL, SE) combining specialist centres with regional care delivery. These models demonstrate considerable variations in their utilisation of inpatient, outpatient, and home-based care services. While these models reflect varying degrees of centralisation and specialisation, they all aim to ensure high-quality care through regulation, accreditation and collaboration, with countries combining elements of different models based on their national cancer strategy and healthcare infrastructure.

                                  For Austria, implementing a gradual transition towards a more decentralised or network-based model could potentially alleviate pressure on hospital resources while enhancing quality of care. However, successful implementation necessitates appropriate infrastructure, qualified healthcare professionals, and effective cross-sectoral coordination. Key challenges include addressing workforce shortages and overcoming fragmented data integration across healthcare sectors.

                                  Publication: HTA Project Report No. 162: https://eprints.aihta.at/1545/ 
                                  Contact: Nicole Grössmann-Waniek

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: „Des Kaisers neue Kleider“ - die Demenzforschung in der Krise
                                  • Nutzenbewertung von KI-Gesundheitstechnologien
                                  • Sektorübergreifende Versorgungsmodelle: Onkologische Brustkrebsversorgung in ausgewählten europäischen Ländern
                                  • Strategien zur Reduzierung von Gewichtsdiskriminierung im Gesundheitswesen
                                  • Screening auf psychische Erkrankungen bei Erwachsenen in der Primärversorgung
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Adobestock-7975543361
                                  ©stock.adobe.com

                                  Announcement

                                  Mental health screening of adults in primary care

                                  With approximately one in five Austrian adults affected by mental illness annually, primarily depression (10%), anxiety disorders (7%), and substance use disorders (12%), screening in primary care settings could help identify and treat affected individuals early. Based on systematic reviews and evidence-based guidelines, this report analyses the evidence for mental health screening in primary care, identifies available screening tools, and discusses the requirements for implementing screening.

                                  Publication: HTA Project Report No. 159: https://eprints.aihta.at/1544
                                  Contact: Julia Kern

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Paxlovid: ein „Magic Bullet” zwischen Mythos und Evidenz
                                  • Ersatzprodukte für Fleisch und Milch: Effekte auf Gesundheit (und Umwelt)
                                  • Nationale Strategien für seltene Erkrankungen
                                  • Früherkennung von Darmkrebs bei Personen mit familiärem Risiko
                                  • Next-Generation-Sequencing (NGS)-Panels für Intelligenzminderung oder globale Entwicklungsverzögerung
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  2194
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce you seven new Fact Sheets.

                                  Fact Sheet Nr. 184 (July 2024)
                                  Toripalimab (Loqtorzi®) in combination with cisplatin and gemcitabine for the first-line treatment of recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC)

                                  Fact Sheet Nr. 185 (July 2024)
                                  Toripalimab (Loqtorzi®) with cisplatin and paclitaxel for the first-line treatment of unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma (OSCC)

                                  Fact Sheet Nr. 186 (July 2024)
                                  Zolbetuximab (Vyloy®) with chemotherapy for the first-line treatment of locally advanced unresectable or metastatic HER2?negative gastric or gastro-oesophageal junction (GEJ) adenocarcinoma

                                  Fact Sheet Nr. 187 (July 2024)
                                  Encorafenib (Braftovi®) in combination with binimetinib (Mektovi®) for the treatment of advanced non-small cell lung cancer (NSCLC)

                                  Fact Sheet Nr. 188 (July 2024)
                                  Pembrolizumab (Keytruda®) with enfortumab vedotin (Padcev®) for the first-line treatment of unresectable or metastatic urothelial carcinoma

                                  Fact Sheet Nr. 189 (July 2024)
                                  Amivantamab (Rybrevant®) in combination with carboplatin and pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC)

                                  Fact Sheet Nr. 190 (July 2024)
                                  Atezolizumab (Tecentriq®) as monotherapy for the first-line treatment of advanced NSCLC

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Korruptionsforschung als aktiver Beitrag zum Handeln gegen Korruption
                                  • Stereotaktische Strahlentherapie, Protonentherapie und irreversible Elektroporation zur Behandlung von lokalisiertem Prostatakrebs
                                  • Analyse österreichischer Krankenversicherungsdaten zur Inanspruchnahme psychischer Gesundheitsleistungen von Frauen vor und während der Peripartalperiode
                                  • D-Dimer- und Troponin-Point of Care Tests (POCT)
                                  • Technologien zur Hochdurchsatz-Analyse genetisch-genomischer Datensätze mittels massiv-paralleler Sequenzierung
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Pimh-models-sb-aihta3
                                  ©AIHTA

                                  Announcement

                                  Uptake of Mental Health Benefits in Women Before and During the Perinatal Period: An Analysis of Austrian Health Insurance Data

                                  On average, one in five women suffer from a mental illness during the perinatal period (pregnancy up to 1 year after birth. So far, it has been unknown how many women claim mental health services during this period. The analysis of pseudonymised insurance data revealed that around 20% of women in Austria who gave birth in 2017 and 2018 used at least one of five examined mental health services during the perinatal period. However, very few specialised perinatal mental health services are available in Austria, with regional disparities. The quality of existing services should be evaluated, and gaps in care need to be closed.

                                  Publication: HTA Project Report No. 154: https://eprints.aihta.at/1535/
                                  Contact: Ingrid Zechmeister-Koss

                                  More...

                                  2193
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce you four new Fact Sheets.

                                  Fact Sheet No. 180 (June 2024)
                                  Erdafitinib (Balversa®) as monotherapy for the treatment of unresectable or metastatic urothelial carcinoma (UC)

                                  Fact Sheet No. 181 (June 2024)
                                  Odronextamab (Ordspono®) as monotherapy for the treatment of relapsed or refractory follicular lymphoma (r/r FL) or diffuse large B?cell lymphoma (r/r DLBCL)

                                  Fact Sheet No. 182 (June 2024)
                                  Durvalumab (Imfinzi®) in combination with carboplatin and paclitaxel for the first-line treatment of primary advanced or recurrent endometrial cancer (EC), followed by maintenance treatment durvalumab (Imfinzi®) as monotherapy in EC that is mismatch repair deficient (dMMR) or in combination with olaparib (Lynparza®) in EC that is mismatch repair proficient (pMMR)

                                  Fact Sheet No. 183 (June 2024)
                                  Epcoritamab (Tepkinly®) as monotherapy for the treatment of relapsed or refractory follicular lymphoma (FL) 

                                  More...

                                  « < 1 2 3 4 5 ... > »
                                  Displaying results 11 to 20.
                                  • News
                                    • Announcements
                                      • Events
                                        • Newsletter
                                          • Press release on our reports
                                            • Press photos
                                            • About us
                                              • Evaluation
                                                • History
                                                  • Methods
                                                    • Team
                                                      • Shareholder & organization chart
                                                        • Stakeholder involvement
                                                          • Press clippings
                                                          • Research areas
                                                            • Oncology
                                                              • High tech medicine
                                                                • Rehabilitation and occupational therapy
                                                                  • Prevention and screening
                                                                    • Psychological & psychiatric interventions
                                                                      • Health economics
                                                                        • European collaboration
                                                                          • HTA-methods & steering instruments
                                                                            • Complementary medicine
                                                                            • Research Projects
                                                                              • Synopsis of current research projects
                                                                                • Synopsis of completed research projects
                                                                                  • Decision Support Documents for the Austrian Appraisal Board
                                                                                    • HTA-Information Service Rapid Reviews
                                                                                      • Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
                                                                                        • Horizon Scanning of Medicines - Reports and Fact Sheets
                                                                                          • Horizon Scanning in Oncology – support for a budget-impact-calculation
                                                                                            • Evaluation of individual medical procedures - Reports
                                                                                              • All projects in an overview
                                                                                              • Publications
                                                                                                • Repository
                                                                                                  • HTA-Newsletter
                                                                                                    • Annual Reports
                                                                                                    • Search
                                                                                                      Netzwerk
                                                                                                      • Eunethta
                                                                                                      • Ebm
                                                                                                      • Inahta
                                                                                                      • Dexhelpp
                                                                                                      Shareholder
                                                                                                      • Bmfg
                                                                                                      • Sv
                                                                                                      • Wgfond
                                                                                                      • Noe
                                                                                                      • Ooghfond
                                                                                                      • Ghls
                                                                                                      • Tirol
                                                                                                      • Vorarlberg
                                                                                                      • Kghfond
                                                                                                      • Ghpf
                                                                                                      • Burgef
                                                                                                      • Contact
                                                                                                        • Imprint
                                                                                                          • Privacy Notice
                                                                                                            • Newsletter
                                                                                                              • Sitemap
                                                                                                                © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                • Log in